Application 077795
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 150MG | No | No |
| 002 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 300MG | No | No |
| 003 | OXCARBAZEPINE | OXCARBAZEPINE | TABLET;ORAL | 600MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077795-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | ||
| A077795-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | ||
| A077795-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077795-002 | OXCARBAZEPINE | 300MG | TABLET / ORAL | 2007-10-09 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077795-003 | OXCARBAZEPINE | 600MG | TABLET / ORAL | 2007-10-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077795-001 | OXCARBAZEPINE | 150MG | TABLET / ORAL | 2007-10-09 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A077795-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A077795-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A077795-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A077795-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077795-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A077795-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A077795-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077795-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A077795-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A077795-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077795-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A077795-003 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 38694974-3dc6-42b5-bdf9-b5354e35330b | 2024-10-25 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Direct_rx | 21b0cc84-b64a-75de-e063-6294a90a9dd0 | 2024-09-09 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | d8edaa2b-3bab-4030-a4e3-0c77f7655731 | 2024-07-16 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | XLCare Pharmaceuticals Inc. | 9f5d17e4-ca68-48e2-9e87-d3ab1c59aa93 | 2024-07-16 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 78f196d4-110e-45b1-813a-725f52c1a4eb | 2024-04-04 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | d3c7a3b8-b9a2-4a5f-98b3-0ed02eca3433 | 2024-04-02 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Biocon Pharma Inc. | 62dfed1d-4c5b-446d-97b3-bad9c33959ff | 2024-03-20 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Bryant Ranch Prepack | 255f64ba-7667-48e6-8599-3b598bf6f4e9 | 2024-01-12 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| OXCARBAZEPINE | OXCARBAZEPINE | Breckenridge Pharmaceutical, Inc. | 682a1210-b26e-426e-8ffe-d25d91bdd608 | 2024-01-09 | Warnings, Adverse reactions | OXCARBAZEPINE OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Precision Dose, Inc. | 636fc847-b3d2-4255-a959-d75499fdb198 | 2023-11-20 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Proficient Rx LP | 95867dcd-fd0e-4570-987b-d35939f7d7d1 | 2022-11-01 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
| Oxcarbazepine | OXCARBAZEPINE | Kanchan Healthcare Inc | 7be73d22-f87b-4459-a91c-37c1e34db230 | Warnings, Adverse reactions | Oxcarbazepine OXCARBAZEPINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0054-0097 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0097 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals | ANDA | Current |
| 0054-0097 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0097 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0097 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0098 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0098 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals | ANDA | Current |
| 0054-0098 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0098 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0098 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0099 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0099 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals | ANDA | Current |
| 0054-0099 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0099 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 0054-0099 | Oxcarbazepine | Oxcarbazepine | West-Ward Pharmaceticals Corp. | ANDA | Current |
| 50090-2573 | Oxcarbazepine | Oxcarbazepine | A-S Medication Solutions | ANDA | Current |
| 55154-4959 | Oxcarbazepine | Oxcarbazepine | Cardinal Health | ANDA | Current |
| 70518-0111 | Oxcarbazepine | Oxcarbazepine | REMEDYREPACK INC. | ANDA | Current |